Neurothekeoma: An analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information

American Journal of Surgical Pathology

Volumn 31, Issue 7, 2007, Pages 1103-1114

  Fetsch, John F ^a   Laskin, William B ^b   Hallman, James R ^a   Lupton, George P ^a   Miettinen, Markku ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cutaneous myxoma; Immunohistochemistry; Nerve sheath myxoma; Neurofibroma; Peripheral nerve sheath tumor; Plexiform fibrohistiocytic tumor; Soft tissue tumor; Superficial angiomyxoma

Indexed keywords

CD68 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN S 100; SMOOTH MUSCLE ACTIN; VIMENTIN;

ADOLESCENT; ADULT; AGED; ARM; ARTICLE; CANCER SURGERY; CHILD; CONSULTATION; DERMIS; DISEASE DURATION; EPITHELIOID CELL; FEMALE; FIBROSIS; FOLLOW UP; HEAD TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; LONG TERM CARE; MALE; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; MITOSIS RATE; MONONUCLEAR CELL; MULTINUCLEAR CELL; MULTIPLE CANCER; NEUROTHEKEOMA; OSTEOCLAST; SHOULDER GIRDLE; SUBCUTANEOUS TISSUE; TUMOR BIOPSY; TUMOR CELL; TUMOR CLASSIFICATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; MIDDLE AGED; NEUROTHEKEOMA; SEX DISTRIBUTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34347341689     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31802d96af     Document Type: Article

References (42)

1. Allen PW. Myxoma is not a single entity: a review of the concept of myxoma. Ann Diagn Pathol. 2000;4:99-123.
2. Allen PW, Dymock RB, MacCormac LB. Superficial angiomyxomas with and without epithelial components. Report of 30 tumors in 28 patients. Am J Surg Pathol. 1988;12:519-530.
3. Angervall L, Kindblom L-G, Haglid K. Dermal nerve sheath myxoma: a light and electron microscopic, histochemical and immunohistochemical study. Cancer. 1984;53:1752-1759.
4. Argenyi ZB, LeBoit PE, Santa Cruz D, et al. Nerve sheath myxoma (neurothekeoma) of the skin: light microscopic and immunohistochemical reappraisal of the cellular variant. J Cutan Pathol. 1993;20:294-303.
5. Barnhill RL, Mihm MC Jr. Cellular neurothekeoma. A distinctive variant of neurothekeoma mimicking nevomelanocytic tumors. Am J Surg Pathol. 1990;14:113-120.
6. Barnhill RL, Dickersin GR, Nickeleit V, et al. Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations. J Am Acad Dermatol. 1991;25(Pt 1):80-88.
7. Bhaskar AR, Kanvinde R. Neurothekeoma of the hand. J Hand Surg [Br]. 1999;24B:631-633.
8. Blumberg AK, Kay S, Adelaar RS. Nerve sheath myxoma of digital nerve. Cancer. 1989;63:1215-1218.
9. Busam KJ, Mentzel T, Colpaert C, et al. Atypical or worrisome features in cellular neurothekeoma. Am J Surg Pathol. 1998;22:1067-1072.
10. Calonje E, Wilson-Jones E, Smith NP, et al. Cellular 'neurothekeoma': an epithelioid variant of pilar leiomyoma? Morphological and immunohistochemical analysis of a series. Histopathology. 1992;20:397-404.
11. Calonje E, Fletcher CDM. Cutaneous fibrohistiocytic tumors: an update. Adv Anat Pathol. 1994;1:2-15.
12. Calonje E, Guerin D, McCormick D, et al. Superficial angiomyxoma: clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. Am J Surg Pathol. 1999;23:910-917.
13. Campbell LK, Thomas JR, Lamps LW, et al. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol. 2003;16:963-969.
14. Carney JA. The Carney complex (myxomas, spotty pigmentation, endocrine overactivity, and schwannomas). Dermatol Clin. 1995;13:19-26.
15. Carney JA, Headington JT, Su WPD. Cutaneous myxomas. A major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol. 1986;122:790-798.
16. Connolly M, Hickey JR, Intzedy L, et al. Subungual neurothekeoma. J Am Acad Dermatol. 2005;52:159-162.
17. Enzinger FM, Zhang R. Plexiform fibrohistiocytic tumor presenting in children and young adults. Am J Surg Pathol. 1988;12:818-826.
18. Fetsch JF, Laskin WB, Tavassoli FA. Superficial angiomyxoma (cutaneous myxoma): a clinicopathologic study of 17 cases arising in the genital region. Int J Gynecol Pathol. 1997;16:325-334.
19. Fetsch JF, Laskin WB, Miettinen M. Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate. Am J Surg Pathol. 2005;29:1615-1624.
20. Fullen DR, Lowe L, Su LD. Antibody to S100a6 protein is a sensitive immunohistochemical marker for neurothekeoma. J Cutan Pathol. 2003;30:118-122.
21. Gallager RL, Helwig EB. Neurothekeoma - a benign cutaneous tumor of neural origin. Am J Clin Pathol. 1980;74:759-764.
22. Harkin JC, Reed RJ. Solitary benign nerve sheath tumors. In: Firminger HI, ed. Atlas of Tumor Pathology, Tumors of the Peripheral Nervous System. Second Series. Washington, DC: Armed Forces Institute of Pathology; 1969:60-64.
23. Hollowood K, Holley MP, Fletcher CDM. Plexiform fibrohistiocytic tumour: clinicopathological, immunohistochemical and ultrastructural analysis in favour of a myofibroblastic lesion. Histopathology. 1991;19:503-513.
24. Husain S, Silvers DN, Halperin AJ, et al. Histologic spectrum of neurothekeoma and the value of immunoperoxidase staing for S-100 protein in distinguishing it from melanoma. Am J Dermatopathol. 1994;16:496-503.
25. Laskin WB, Fetsch JF, Miettinen M. The "neurothekeoma": immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Hum Pathol. 2000;31:1230-1241.
26. Mahalingam M, Alter JN, Bhawan J. Multiple cellular neurothekeomas - a case report and review on the role of immunohistochemistry as a histologic adjunct. J Cutan Pathol. 2006;33:51-56.
27. Mechtersheimer G. Towards the phenotyping of soft tissue tumours by cell surface molecules. Virchows Arch A Pathol Anat Histopathol. 1991;419:7-28.
28. Mechtersheimer G, Moller P. Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors. Am J Pathol. 1989;134:961-965.
29. Miettinen M, Fetsch JF. Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol. 2006;30:521-528.
30. Miettinen M, Fernandez M, Franssila K, et al. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol. 2001;25:205-211.
31. Misago N, Satoh T, Narisawa Y. Cellular neurothekeoma with histiocytic differentiation. J Cutan Pathol. 2004;31:568-572.
32. Page RN, King R, Mihm MC Jr, et al. Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Mod Pathol. 2004;17:134-230.
33. Pulitzer DR, Reed RJ. Nerve-sheath myxoma (perineurial myxoma). Am J Dermatopathol. 1985;7:409-421.
34. Remstein ED, Arndt CA, Nascimento AG. Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases. Am J Surg Pathol. 1999;23:662-670.
35. Sachdev R, Sundram UN. Frequent positive staining with NKI/C3 in normal and neoplastic tissues limits its usefulness in the diagnosis of cellular neurothekeoma. Am J Clin Pathol. 2006;126:1-10.
36. Salomao DR, Nascimento AG. Plexiform fibrohistiocytic tumor with systemic metastases: a case report. Am J Surg Pathol. 1997;21:469-476.
37. Scheithauer BW, Woodruff JM, Erlandson RA. Miscellaneous benign neurogenic tumors. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology, Tumors of the Peripheral Nervous System. Third Series. Washington, DC: Armed Forces Institute of Pathology; 1999:219-282.
38. Seethala RR, Goldblum JR, Hicks DG, et al. Immunohistochemical evaluation of microphthalmia-associated transcription factor expression in giant cell lesions. Mod Pathol. 2004;17:1491-1496.
39. Wang AR, May D, Bourne P, et al. PGP9*5: a marker for cellular neurothekeoma. Am J Surg Pathol. 1999;23:1401-1407.
40. Webb JN. The histogenesis of nerve sheath myxoma: report of a case with electron microscopy. J Pathol. 1979;127:35-37.
41. Yamamoto H, Kawana T. Oral nerve sheath myxoma. Report of a case with findings of ultrastructural and immunohistochemical studies. Acta Pathol Jpn. 1988;38:121-127.
42. Zelger BG, Steiner H, Kutzner H, et al. Cellular 'neurothekeoma': an epithelioid variant of dermatofibroma? Histopathology. 1998;32:414-422.